News and Trends 26 Oct 2022
Scancell signs agreement with Genmab
Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer and infectious disease, has signed a licensing agreement with Genmab, an international biotechnology company, to develop and…